NCT00257426已完成2 期
A Phase II Study of Octreotide Acetate for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 31
- 试验地点
- 2
- 主要终点
- Median survival
研究概览
简要总结
RATIONALE: Octreotide may stop or slow the growth of tumor cells and may be an effective treatment for liver cancer.
PURPOSE: This phase II trial is studying how well octreotide works in treating patients with locally advanced or metastatic liver cancer.
详细描述
OBJECTIVES:
Primary
- To verify that long-acting somatostatin analog octreotide (Sandostatin LAR) depot will extend median survival from 5 months to 8.75 months in patients with locally advanced or metastatic hepatocellular carcinoma with a CLIP score of 3 or more.
Secondary
- To document tolerability of this drug in this patient population.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Median survival
时间窗: 6 months
次要结局
- number of subjects with toxicities(6 months)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent ThymomaThymoma and Thymic CarcinomaNCT00003283Eastern Cooperative Oncology Group38
已完成
1 期
Octreotide and Doxorubicin in Treating Patients With Advanced CancerUnspecified Adult Solid Tumor, Protocol SpecificNCT00008073University of Pittsburgh
已完成
2 期
AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine TumorsGastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic SyndromeNCT00427349Eastern Cooperative Oncology Group46
撤回
2 期
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine TumorsGastrointestinal Carcinoid TumorIslet Cell CarcinomaNCT00227773Eastern Cooperative Oncology Group
已完成
2 期
Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic SyndromeMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative NeoplasmsLeukemiaAnemiaNCT00053001Fallon Clinic